Tetrahydrocannabinol
Research News and Information

Sunday, November 22, 2009

Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.

29 Sep 2009 BACKGROUND: The European DRUID (Driving under the Influence of Drugs, Alcohol And Medicines) project calls for analysis of oral fluid (OF) samples, collected randomly and anonymously at the roadside from drivers in Denmark throughout 2008-2009. To ... Read more...

Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.

29 Sep 2009 Gliomas, one of the most malignant forms of cancer, exhibit high resistance to conventional therapies. Identification of the molecular mechanisms responsible for this resistance is therefore of great interest to improve the efficacy of the ... Read more...

Inadvertent ingestion of marijuana - Los Angeles, California, 2009.

2 Sep 2009 On April 8, 2009, the Los Angeles Police Department (LAPD) notified officials from the Los Angeles County Department of Public Health (DPH) in California about a group of preschool teachers with nausea, dizziness, headache, and numbness and tingling ... Read more...

Latest indexed articles for 'Tetrahydrocannabinol'

These are the very latest articles for this heading:

• Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. 29 Sep 2009
• Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. 29 Sep 2009
• How pot became legal. 26 Sep 2009
• Inadvertent ingestion of marijuana - Los Angeles, California, 2009. 2 Sep 2009
• Comprehensive analysis of drugs of abuse in urine using disposable pipette extraction. 30 Aug 2009
• A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood. 30 Aug 2009
• Get stoned in GABAergic synapses. 30 Aug 2009
• Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. 31 Jul 2009
• Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. 30 Jul 2009
• Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. 30 Jul 2009
• Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence. 18 Jul 2009
• Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? 29 Jun 2009
• Can recreational doses of THC produce significant dopamine release in the human striatum? 15 Jun 2009
• An evaluation of microwave-assisted derivatization procedures using hyphenated mass spectrometric techniques. 15 Jun 2009
• Elicitation studies in cell suspension cultures of Cannabis sativa L. 9 Jun 2009
• Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. 7 Jun 2009
• Effects of gibberellic acid on primary terpenoids and delta-tetrahydrocannabinol in Cannabis sativa at flowering stage. 30 May 2009
• Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. 30 May 2009
• Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. 21 May 2009
• On-line solid-phase extraction combined with liquid chromatography-tandem mass spectrometry for high throughput analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in urine. 19 May 2009

See a longer list of these articles.

Technical information about 'Tetrahydrocannabinol'

Definition: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.

Chemical name: 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-

Registry Number: 1972-08-3

Descriptor UI: D013759

Alternative terms: Tetrahydrocannabinol; delta(1)-Tetrahydrocannabinol; THC; delta(9)-Tetrahydrocannabinol; delta(9)-THC; Dronabinol; 9-ene-Tetrahydrocannabinol; 9 ene Tetrahydrocannabinol; delta(1)-THC; Tetrahydrocannabinol, (6a-trans)-Isomer; Tetrahydrocannabinol, Trans-Isomer; Tetrahydrocannabinol, Trans Isomer; Tetrahydrocannabinol, (6aS-cis)-Isomer; Tetrahydrocannabinol, Trans-(+-)-Isomer; Marinol; Solvay Brand of Tetrahydrocannabinol; Tetrahydrocannabinol, (6aR-cis)-Isomer;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis;

Pharmacological Action: Hallucinogens; Psychotropic Drugs; Analgesics, Non-Narcotic;

Tree Number: D02.455.849.090.810;

History Note: 77(71); was see under CANNABIS 1975-76